annb0t
Top 20
Ongoing trial to assess the potential of Zilosul⢠to address unmet medical need in OA which affects more than 72 million people in the U.S., EU5, and Canada
Key Highlights
The first subjects have now commenced dosing in the PARA_OA_002 Phase III study in activated sites in the U.S. To date, 21 sites have begun screening and recruiting potential candidates. With the initiation of 56 selected sites in the U.S., Paradigm now has a large potential pool of candidates to screen.
NEW YORK, May ...
>>> Read more: First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA
Key Highlights
The first subjects have now commenced dosing in the PARA_OA_002 Phase III study in activated sites in the U.S. To date, 21 sites have begun screening and recruiting potential candidates. With the initiation of 56 selected sites in the U.S., Paradigm now has a large potential pool of candidates to screen.
NEW YORK, May ...
>>> Read more: First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA
